About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06189079

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study

To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of diseas...

Lead sponsor: Istituto Ortopedico Rizzoli•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Istituto Ortopedico Rizzoli

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients of either sex of age or older who are candidates for embolization therapy
•Life expectancy \> 3 months
•Single metastatic or oligometastatic.
•Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture

Exclusion Criteria

•Patients with life expectancy \<3 months or severe functional status impairment (ASA 4)
•Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC.
•Patients with coagulation deficiency or plateletopenic patients.
•Patients with documented active infection.

Related studies

Registry for Bone Metastases

NCT07391410 · Bone Metastases

RECRUITINGPhase 1

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

NCT07197645 · Bone Pain, Metastatic Bone Tumor, and more

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

NCT06480955 · Bone Metastases

Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases

NCT07202273 · Bone Metastases

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

NCT06987370 · Bone Metastases in Subjects With Advanced Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 17, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment60

Start dateMay 2023

Last updatedJun 17, 2025

Condition

Bone Metastases

Locations shown

Istituto Ortopedico Rizzoli

Bologna, Emilia-Romagna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 17, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions